Back to results
US 2021/0171564 A1Published application
Compositions and methods for the treatment of cancer
AssigneeCellix Bio Provate Limited
InventorMahesh Kandula
Life of this patent
Estimating the term…
Abstract
The compositions and compounds of formula I and formula II which includes nucleic acid synthesis inhibitor conjugates or its polymorphs, enantiomers, stereoisomers, solvates, and hydrates thereof. These conjugates may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for oral administration, intravenous, solution, syrup, sachet, transdermal administration, or injection. Such compositions may be used to treatment of cancer or its associated complications.
Claims12
A compound of Formula I:
- and pharmaceutically acceptable salts, hydrates, solvates, prodrugs, enantiomers, and stereoisomers thereof;
- wherein
- R1, R3, R5 independently represents NULL,
- R2, R4 independently represent NULL, hydrogen,
- R6 independently represents NULL,
- within the proviso,
- wherein
- n represents 0 to 12;
- R7 and R8 independently represents
- with the proviso that when R2 and R4 is hydrogen then R6 is not
7 more elements
A compound of Formula II:
- and pharmaceutically acceptable hydrates, solvates, prodrugs, enantiomers, and stereoisomers thereof,
- wherein
- R1, R3, R5 independently represents NULL,
- R2, R4 independently represent NULL, hydrogen,
- R6 independently represents NULL,
- wherein, n represents 0 to 12;
- with the proviso that when R2 and R4 is hydrogen then R6 is not
4 more elements
A compound selected from the group consisting of
Dependencies are inferred from the claim text.